back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-05-09 19:22 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Warrants
57 - Exercise of rights
|
+52,080 vol |
52,080 | |
| Filed 2023-05-09 19:20 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$13,020
+52,080 vol $0.25 each |
114,760 | |
| Filed 2023-05-09 19:20 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights
58 - Expiration of rights
|
-10,600 vol |
0 | |
| Filed 2023-05-09 19:19 Tx date 2023-05-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights
57 - Exercise of rights
|
-52,080 vol |
10,600 | |
| Filed 2023-04-17 21:59 Tx date 2023-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+62,680 vol |
62,680 | |
| Filed 2023-04-17 21:59 Tx date 2015-10-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-14 13:29 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
37 - Stock split or consolidation
|
+20,001 vol |
26,668 | |
| Filed 2023-03-14 13:28 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+15,000 vol |
62,000 | |
| Filed 2023-03-14 13:27 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+19,500 vol |
47,000 | |
| Filed 2023-03-14 13:26 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+6,000 vol |
27,500 | |
| Filed 2023-03-14 13:25 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+6,000 vol |
21,500 | |
| Filed 2023-03-14 13:24 Tx date 2023-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
55 - Expiration of warrants
|
-500 vol |
15,500 | |
| Filed 2023-03-14 13:24 Tx date 2022-05-18 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
55 - Expiration of warrants
|
-500 vol |
11,000 | |
| Filed 2023-03-14 13:23 Tx date 2023-03-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
+47,010 vol |
62,680 | |
| Filed 2023-01-16 17:04 Tx date 2023-01-16 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,333 vol |
15,670 | |
| Filed 2023-01-16 17:03 Tx date 2023-01-16 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-3,333 vol |
6,667 | |
| Filed 2022-09-05 19:08 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+10,000 vol |
10,000 | |
| Filed 2022-09-05 19:07 Tx date 2022-08-31 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+5,000 vol |
16,500 | |
| Filed 2022-04-14 12:41 Tx date 2022-04-12 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,607
+900 vol $6.23 each |
12,337 | |
| Filed 2022-01-21 19:58 Tx date 2021-08-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-85,000 vol |
0 | |
| Filed 2022-01-21 19:57 Tx date 2022-01-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+6,500 vol |
11,500 | |
| Filed 2022-01-21 19:56 Tx date 2021-11-23 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-495,000 vol |
5,000 | |
| Filed 2022-01-21 19:54 Tx date 2021-11-23 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,132,285 vol |
11,437 | |
| Filed 2021-12-31 14:47 Tx date 2021-12-30 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$275,000
+500,000 vol $0.55 each |
1,800,000 | |
| Filed 2021-02-19 14:23 Tx date 2018-10-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-1,000,000 vol |
1,000,000 | |
| Filed 2021-02-19 14:22 Tx date 2021-01-21 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+73,118 vol |
1,143,722 | |
| Filed 2021-02-19 14:22 Tx date 2020-09-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+70,604 vol |
1,070,604 | |
| Filed 2021-02-19 14:21 Tx date 2021-01-21 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-82,500 vol |
85,000 | |
| Filed 2021-02-19 14:20 Tx date 2020-09-29 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
57 - Exercise of rights
|
-82,500 vol |
167,500 | |
| Filed 2021-02-19 14:17 Tx date 2020-07-23 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
56 - Grant of rights
|
+250,000 vol |
250,000 | |
| Filed 2021-02-19 14:17 Tx date 2015-10-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Rights RSUs
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-19 14:15 Tx date 2020-10-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-1,000,000 vol |
0 | |
| Filed 2021-02-19 14:13 Tx date 2020-04-13 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
750,000 | |
| Filed 2021-02-19 14:11 Tx date 2018-10-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-50,000 vol |
350,000 | |
| Filed 2021-02-19 14:10 Tx date 2018-10-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-50,000 vol |
400,000 | |
| Filed 2021-02-19 14:08 Tx date 2021-02-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-250,000 vol |
500,000 | |
| Filed 2021-01-22 20:56 Tx date 2021-01-22 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-50,000 vol |
2,140,703 | |
| Filed 2021-01-22 20:47 Tx date 2021-01-12 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,250,000 vol |
2,190,703 | |
| Filed 2020-03-02 23:09 Tx date 2020-02-25 |
$AGN
Algernon Pharmaceuticals Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
650,000 | |
| Filed 2019-09-29 23:41 Tx date 2019-09-28 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-653,047 vol |
940,703 | |
| Filed 2019-09-29 20:15 Tx date 2019-09-23 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+450,000 vol |
1,300,000 | |
| Filed 2018-03-01 Tx date 2018-03-01 |
$BTH
Breathtec BioMedical, Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+100,000 vol $0.24 each |
450,000 | |
| Filed 2017-12-06 Tx date 2017-12-06 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-281,250 vol |
1,593,750 | |
| Filed 2017-05-23 Tx date 2017-05-18 |
$BTH
Breathtec BioMedical, Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+100,000 vol $0.15 each |
350,000 | |
| Filed 2017-01-25 Tx date 2017-01-25 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
850,000 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+300,000 vol $0.35 each |
550,000 | |
| Filed 2016-03-30 Tx date 2016-03-01 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
-1,875,000 vol |
1,875,000 | |
| Filed 2016-01-07 Tx date 2015-10-26 |
$
Breathtec BioMedical, Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
| Filed 2016-01-07 Tx date 2015-10-26 |
$
Breathtec BioMedical, Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,000,000 | ||
| Filed 2016-01-07 Tx date 2015-10-26 |
$
Breathtec BioMedical, Inc. |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000,000 | ||
| Filed 2015-06-17 Tx date 2015-06-17 |
$BLO
Cannabix Technologies Inc |
Attariwala, Rajpaul
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+1,875,000 vol |
3,750,000 |